Division of Neuroscience, Harvard Medical School/NEPRC, Southborough, MA, USA.
J Neurosci Res. 2010 Jul;88(9):1962-9. doi: 10.1002/jnr.22367.
3-Iodothyronamine (T1AM) is a metabolite of thyroid hormone. It is an agonist at trace amine-associated receptor 1 (TAAR1), a recently identified receptor involved in monoaminergic regulation and a potential novel therapeutic target. Here, T1AM was studied using rhesus monkey TAAR1 and/or human dopamine transporter (DAT) co-transfected cells, and wild-type (WT) and TAAR1 knock-out (KO) mice. The IC(50) of T1AM competition for binding of the DAT-specific radio-ligand [(3)H]CFT was highly similar in DAT cells, WT striatal synaptosomes and KO striatal synaptosomes (0.72-0.81 microM). T1AM inhibition of 10 nM [(3)H]dopamine uptake (IC(50): WT, 1.4 + or - 0.5 microM; KO, 1.2 + or - 0.4 microM) or 50 nM [(3)H]serotonin uptake (IC(50): WT, 4.5 + or - 0.6 microM; KO, 4.7 + or - 1.1 microM) in WT and KO synaptosomes was also highly similar. Unlike other TAAR1 agonists that are DAT substrates, TAAR1 signaling in response to T1AM was not enhanced in the presence of DAT as determined by CRE-luciferase assay. In vivo, T1AM induced robust hypothermia in WT and KO mice equivalently and dose dependently (maximum change degrees Celsius: 50 mg/kg at 60 min: WT -6.0 + or - 0.4, KO -5.6 + or - 1.0; and 25 mg/kg at 30 min: WT -2.7 + or - 0.4, KO -3.0 + or - 0.2). Other TAAR1 agonists including beta-phenylethylamine (beta-PEA), MDMA (3,4-methylenedioxymethamphetamine) and methamphetamine also induced significant, time-dependent thermoregulatory responses that were alike in WT and KO mice. Therefore, TAAR1 co-expression does not alter T1AM binding to DAT in vitro nor T1AM inhibition of [(3)H]monoamine uptake ex vivo, and TAAR1 agonist-induced thermoregulatory responses are TAAR1-independent. Accordingly, TAAR1-directed compounds will likely not affect thermoregulation nor are they likely to be cryogens.
3-碘甲状腺原氨酸(T1AM)是甲状腺激素的一种代谢产物。它是一种痕量胺相关受体 1(TAAR1)的激动剂,TAAR1 是最近发现的一种参与单胺能调节的受体,也是一种有潜力的新型治疗靶点。在这里,使用恒河猴 TAAR1 和/或人多巴胺转运体(DAT)共转染细胞以及野生型(WT)和 TAAR1 敲除(KO)小鼠研究了 T1AM。T1AM 与 DAT 特异性放射性配体[3H]CFT 结合的竞争 IC50 在 DAT 细胞、WT 纹状体突触体和 KO 纹状体突触体中非常相似(0.72-0.81μM)。T1AM 抑制 10 nM[3H]多巴胺摄取(IC50:WT,1.4+/-0.5μM;KO,1.2+/-0.4μM)或 50 nM[3H]血清素摄取(IC50:WT,4.5+/-0.6μM;KO,4.7+/-1.1μM)在 WT 和 KO 突触体中也非常相似。与其他作为 DAT 底物的 TAAR1 激动剂不同,通过 CRE-荧光素酶测定法,在 DAT 存在的情况下,TAAR1 信号对 T1AM 的反应没有增强。在体内,T1AM 以剂量依赖的方式在 WT 和 KO 小鼠中同样引起强烈的体温降低(最大变化摄氏度:60 分钟时 50mg/kg:WT-6.0+/-0.4,KO-5.6+/-1.0;30 分钟时 25mg/kg:WT-2.7+/-0.4,KO-3.0+/-0.2)。其他 TAAR1 激动剂,包括β-苯乙胺(β-PEA)、MDMA(3,4-亚甲基二氧甲基苯丙胺)和苯丙胺,也诱导了显著的、时间依赖性的体温调节反应,在 WT 和 KO 小鼠中相似。因此,TAAR1 共表达不会改变 T1AM 在体外与 DAT 的结合,也不会改变 T1AM 对[3H]单胺摄取的抑制作用,而 TAAR1 激动剂诱导的体温调节反应是 TAAR1 非依赖性的。因此,针对 TAAR1 的化合物可能不会影响体温调节,也不太可能成为低温剂。